港股异动 | 乐普生物-B(02157)再涨超6% 自研ADC药物MRG004A启动III期胰腺癌临床
Last Update:
5 8 月, 2025
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.